For information only. Not investment advice, a recommendation, an offer or a solicitation, and without regard to any recipient’s objectives or circumstances. Figures come from third-party sources believed reliable but not guaranteed, and market data may be delayed. Past performance is not a reliable indicator of future results. | ||||||||||||||||||||||||||||||||||||||||||||||||
![]() Syensqo SASYENS BB · Industrials · EUR Current priceEUR 77.95as of Nov 19, 2026 Summary
Analyst consensusStrong Buy 2Buy 5Hold 7Sell 115 analysts 3-year price (EUR)Factor profileMulti-factor score 5 / 100 Market data
Business descriptionSyensqo SA is a Belgian specialty materials company, spun off from Solvay in December 2023, focused on specialty polymers, composite materials, and biotechnology-derived materials for aerospace, defense, electronics and healthcare end markets. Its Composite Materials segment supplies advanced carbon-fiber composites and prepregs to commercial aerospace, defense and helicopter programs under long-term qualified contracts, while Specialty Polymers serves semiconductor, automotive and industrial customers requiring high-performance, application-specific materials. Competitive moat
Recent developments
Investment risks / red flags
Financials
Classification
|
Last updated: Aug 12, 2026
Current price: EUR 77.95 · Nov 19, 2026· EUR
CFRA Ratingbuy
TBI Multi Score5
Theme Exposure
Loading graph…
Factor Profile (Spider Chart)
TBI ModelPrice Chart
SYENS.BR75.35EUR+11.8%
Daily closes · Yahoo Finance · TradingView does not carry this exchange
Business description
Syensqo SA is a Belgian specialty materials company, spun off from Solvay in December 2023, focused on specialty polymers, composite materials, and biotechnology-derived materials for aerospace, defense, electronics and healthcare end markets. Its Composite Materials segment supplies advanced carbon-fiber composites and prepregs to commercial aerospace, defense and helicopter programs under long-term qualified contracts, while Specialty Polymers serves semiconductor, automotive and industrial customers requiring high-performance, application-specific materials.
Competitive moat
- Aerospace Composite Materials Leadership: Long-term qualified positions on commercial aerospace, defense and helicopter programs create high switching costs; the segment posted its strongest quarter on record in Q2 2026 (organic sales +18% YoY) on aerospace demand.
- Technical Differentiation in Specialty Polymers: High-performance polymers for semiconductor, automotive and industrial applications sustain pricing power even amid cyclical industrial softness.
- Structural Growth End-Markets: Concentrated exposure to aerospace/defense build rates and electronics/energy-transition applications provides secular demand support relatively insulated from broader European industrial cyclicality.
- Post-Spin Portfolio Focus: Ongoing strategic review of the lower-margin Performance & Care segment (~17.8% EBITDA margin) signals a shift toward a purer, higher-margin Materials-led mix (Materials already ~72% of underlying EBITDA).
Recent developments
- 2026-07-30: Reported Q2 2026 results — net sales EUR 1.55B (+5% volume growth YoY), underlying EBITDA EUR 311M (+24% sequentially, beating consensus by 7%), driven by Composite Materials organic sales +18% YoY (strongest quarter on record); shares jumped ~8% on the print. Raised FY2026 underlying EBITDA guidance to "at least" EUR 1.1B (from "around" EUR 1.1B) and upgraded volume growth outlook to low-to-mid single digit (from low single digit).
- 2026-05-21: Launched a strategic review of the Performance & Care segment (Novecare + Technology Solutions, ~EUR 2.0B 2025 sales, EUR 358M underlying EBITDA), exploring options including a potential sale to sharpen focus on specialty materials, aerospace/defense, and electronics end markets; the company states there is no certainty on outcome or structure.
- 2026-05-15: Reported Q1 2026 results — net sales EUR 1.4B, underlying EBITDA EUR 251M (+6% sequentially, in line with guidance); completed the divestment of its Oil & Gas business to SNF Group and trimmed 2026 capex guidance by up to EUR 50M.
Investment risks / red flags
- ⚠️ Sector Cyclicality Outside Aerospace: Specialty Polymers and Performance & Care remain exposed to broader industrial and consumer cycles, even as Composite Materials outperforms.
- ⚠️ Portfolio Transition/Execution Risk: The strategic review of Performance & Care (a ~EUR 2.0B-sales unit) creates execution and disclosure uncertainty, with the company itself flagging no certainty on outcome.
- ⚠️ Extremely Weak H-Score Quality: A Quality sub-factor of just 3 against Momentum of 75 signals the recent rally has run well ahead of underlying profitability/quality metrics — a valuation risk if aerospace momentum stalls.
- ⚠️ Standalone Cost Base: As a company spun off from Solvay in December 2023, Syensqo is still normalizing its standalone cost structure and exiting transitional service agreements, which weighs on near-term free cash flow visibility.
Market Data
Source: mkts.io · Nov 19, 2026, 08:00 UTC
Key Metrics
P/E (Fwd)18.44
Dividend2.08%
Beta0.52
52W HighEUR 83.40
52W LowEUR 41.76
Analyst Consensus
2
5
7
Strong Buy2Buy5Hold7Sell115 analysts
Consensus TargetEUR 84.37
+8.2% upside
Calendar Events
Next EarningsNov 5, 2026
Ex-DividendMay 14, 2026
Financials
RevenueEUR 6.08B
Rev Growth10.60%
Earnings Growth83.90%
Gross Margin30.60%
Op Margin6.53%
Profit Margin0.13%
EBITDAEUR 1.13B
ROA2.11%
ROE-0.51%
Rev/ShareEUR 59.60
Total CashEUR 619.00M
Total DebtEUR 2.56B
D/E Ratio40.99
Free Cash FlowEUR 540.88M
Op Cash FlowEUR 749.00M
Current Ratio1.78
Forward Estimates
| Period | EPS Est | Rev Est |
|---|---|---|
| 0q | 0.65 | EUR 1.44B |
| +1q | 0.84 | EUR 0.00 |
| 0y | 3.51 | EUR 6.06B |
| +1y | 4.23 | EUR 6.34B |
Earnings
Quarterly EPS
4Q2025
Est: 0.780.30Miss
1Q2026
Est: 0.660.66Beat
2Q2026
Est: 0.941.03Beat
3Q2026
Est: 1.111.06Miss
Annual
2023
Rev EUR 6.83BEarn EUR 193.00M
2024
Rev EUR 6.56BEarn -EUR 5.00M
2025
Rev EUR 6.14BEarn -EUR 62.00M
Rating Changes
| Date | Firm | Action | To |
|---|---|---|---|
| Mar 27, 2024 | Jefferies | init | Hold |
